Biggest News Aggregation in the World
📰 Erick Fair News

Erick Fair News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Erick Fair. Real-time updates on events, politics, business and more.

Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update

24.03.2022 - - Confirmed partial response in one of the first three metastatic castration-resistant prostate cancer (mCRPC) patients treated with BPX-601 in Phase 1/2 study - - Favorable safety profile observed in initial dose cohort of BPX-603 in HER2+ solid ...
United States Roberth Uhl Abbvie Stemcentrx Bellicum Go Bellicum Pharmaceuticals Inc Clinical Medical Affairs At Bellicum

Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603

Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603 HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced enrollment and apheresis of the first patient in the Phase 1/2 clinical trial for BPX-603 in patients with tumors that express human epidermal growth factor 2 (HER2). BPX-603 is Bellicum’s first dual switch GoCAR-T ® product candidate th...
United States Roberth Uhl Bellicum Go Bellicum Pharmaceuticals Inc Exchange Commission Bellicum Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science